BlinkLab (ASX: BB1) is a promising small-cap AI healthcare stock with a novel autism diagnostic tool, making it a strong buy opportunity.
Source Post
This reel discusses BlinkLab Limited (ASX: BB1), a small-cap AI healthcare company focused on autism diagno...
Jun 1, 2026
This reel discusses BlinkLab Limited (ASX: BB1), a small-cap AI healthcare company focused on autism diagnosis. It highlights the challenges in current diagnosis methods and BlinkLab's patented smartphone app, Dx1, which uses AI to analyze facial reflexes and other cues for a faster, more objective diagnosis. The company has secured a government-funded autism screening program in Morocco, indicating significant growth potential.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
BB1.AXbuy opened Jun 1, 2026
-7.69%